Like, why isn't everybody doing it? But you don't see consistent application across the industry, right? So the thing is,

I would say a lot of companies are already following this guidance and these regulations because it's a big part of the contamination control, as you already mentioned.

the risk-based approach, which is more and more the focus in the industry, right? So basically, what the Annex 1 is describing is not really new for the industry, but it is written down in a compact paper and describes all the important things which are necessary to follow up to be able to produce safe drugs.

And therefore, the Annex 1 or the Annex term NX1 is easy to explain in a certain some words it's Just a regulation or an overview how to produce drugs for safe drugs for the patients.

That's a

it's

much, much more behind this.

As you said, the facility layout is one topic.